Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce R Schackman

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
Plos One|December 27, 2018
No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305Shashi N Kapadia, Chunyuan Wu, Kenneth H Mayer, et al.
Substance Abuse Treatment, Prevention, and Policy|April 9, 2021
Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder researchMichelle A Papp, Jared A Leff, Sean M Murphy, et al.
Drug and Alcohol Dependence|September 14, 2012
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trialBruce R Schackman, Lisa R Metsch, Grant N Colfax, et al.
The Journal of Infectious Diseases|January 28, 2010
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failureRoger Paredes, Christina M Lalama, Heather J Ribaudo, et al.
Addiction Science & Clinical Practice|February 20, 2019
Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatmentJennifer McNeely, Andrea B Troxel, Hillary V Kunins, et al.
BMC Health Services Research|March 25, 2017
The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto RicoJared A Leff, Diana Hernández, Paul A Teixeira, et al.
Addiction (Abingdon, England)|October 25, 2024
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United StatesXiao Zang, Alexandra Skinner, Zongbo Li, et al.
Open Forum Infectious Diseases|January 8, 2020
Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles CountyMoses J E Flash, Wendy H Garland, Emily B Martey, et al.
Open Forum Infectious Diseases|May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|January 17, 2025
Expanded Naloxone Distribution by Opioid Overdose Prevention Programs to High-Need Populations and Neighborhoods in New York CityCzarina N Behrends, Andrew J Trinidad, Michelle L Nolan, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Plos One|December 27, 2018
No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305Shashi N Kapadia, Chunyuan Wu, Kenneth H Mayer, et al.
Substance Abuse Treatment, Prevention, and Policy|April 9, 2021
Harmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder researchMichelle A Papp, Jared A Leff, Sean M Murphy, et al.
Drug and Alcohol Dependence|September 14, 2012
The cost-effectiveness of rapid HIV testing in substance abuse treatment: results of a randomized trialBruce R Schackman, Lisa R Metsch, Grant N Colfax, et al.
The Journal of Infectious Diseases|January 28, 2010
Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failureRoger Paredes, Christina M Lalama, Heather J Ribaudo, et al.
Addiction Science & Clinical Practice|February 20, 2019
Study protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatmentJennifer McNeely, Andrea B Troxel, Hillary V Kunins, et al.
BMC Health Services Research|March 25, 2017
The structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto RicoJared A Leff, Diana Hernández, Paul A Teixeira, et al.
Addiction (Abingdon, England)|October 25, 2024
Improving racial/ethnic health equity and naloxone access among people at risk for opioid overdose: A simulation modeling analysis of community-based naloxone distribution strategies in Massachusetts, United StatesXiao Zang, Alexandra Skinner, Zongbo Li, et al.
Open Forum Infectious Diseases|January 8, 2020
Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles CountyMoses J E Flash, Wendy H Garland, Emily B Martey, et al.
Open Forum Infectious Diseases|May 9, 2017
Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1Benjamin P Linas, Jake R Morgan, Mai T Pho, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|January 17, 2025
Expanded Naloxone Distribution by Opioid Overdose Prevention Programs to High-Need Populations and Neighborhoods in New York CityCzarina N Behrends, Andrew J Trinidad, Michelle L Nolan, et al.
Pageof 23